FGC
AMAG

Financial Gravity Companies’s AMAG Pharmaceuticals AMAG Stock Holding History

Financial Gravity Companies’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$9K Buy
+463
New +$7.83K 0.01% 611

Other funds holding AMAG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Financial Gravity Companies's AMAG Position: Q1 2018 in Review

Financial Gravity Companies opened a new position in AMAG Pharmaceuticals (AMAG) in Q1 2018: 463 shares worth $9K. The stake represents 0.01% of the portfolio and ranks #611 among its holdings.

170 funds tracked by Wall St. Rank hold AMAG as of Q1 2018.

  • Financial Gravity Companies held 463 shares of AMAG Pharmaceuticals worth $9K as of Q1 2018.
  • AMAG Pharmaceuticals was a new Financial Gravity Companies position in Q1 2018.
  • AMAG Pharmaceuticals made up 0.01% of Financial Gravity Companies's portfolio in Q1 2018, its #611 holding.
  • 170 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2018.

Based on Financial Gravity Companies's 13F filing for Q1 2018, filed 4 May 2018.